In VitroEfficacy of Dicationic Compounds and Mefloquine Enantiomers against Echinococcus multilocularis Metacestodes
- 1 October 2011
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (10) , 4866-4872
Abstract
The current chemotherapy of alveolar echinococcosis (AE) is based on benzimidazoles such as albendazole and has been shown to be parasitostatic rather than parasiticidal, requiring lifelong duration. Thus, new and more efficient treatment options are urgently needed. By employing a recently validated assay based on the release of functional phosphoglucose isomerase (PGI) from dying parasites, the activities of 26 dicationic compounds and of the (+)- and (−)-erythro-enantiomers of mefloquine were investigated. Initial screening of compounds was performed at 40 μM, and those compounds exhibiting considerable antiparasitic activities were also assessed at lower concentrations. Of the dicationic drugs, DB1127 (a diguanidino compound) with activities comparable to nitazoxanide was further studied. The activity of DB1127 was dose dependent and led to severe structural alterations, as visualized by electron microscopy. The (+)- and (−)-erythro-enantiomers of mefloquine showed similar dose-dependent effects, although higher concentrations of these compounds than of DB1127 were required for metacestode damage. In conclusion, of the drugs investigated here, the diguanidino compound DB1127 represents the most promising compound for further study in appropriatein vivomodels forEchinococcus multilocularisinfection.Keywords
This publication has 55 references indexed in Scilit:
- In VitroandIn VivoEfficacies of Mefloquine-Based Treatment against Alveolar EchinococcosisAntimicrobial Agents and Chemotherapy, 2011
- Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease TreatmentAntimicrobial Agents and Chemotherapy, 2010
- Novel Arylimidamides for Treatment of Visceral LeishmaniasisAntimicrobial Agents and Chemotherapy, 2010
- New Treatment Option for Second-Stage African Sleeping Sickness: In Vitro and In Vivo Efficacy of Aza Analogs of DB289Antimicrobial Agents and Chemotherapy, 2009
- Advancing Drug Innovation for Neglected Diseases—Criteria for Lead ProgressionPLOS Neglected Tropical Diseases, 2009
- Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in MicePLOS Neglected Tropical Diseases, 2009
- In Vitro and In Vivo Treatments of Echinococcus Protoscoleces and Metacestodes with Artemisinin and Artemisinin DerivativesAntimicrobial Agents and Chemotherapy, 2008
- Host Cells Participate in the In Vitro Effects of Novel Diamidine Analogues against Tachyzoites of the Intracellular Apicomplexan ParasitesNeospora caninumandToxoplasma gondiiAntimicrobial Agents and Chemotherapy, 2008
- In Vitro Metacestodicidal Activities of Genistein and Other Isoflavones against Echinococcus multilocularis and Echinococcus granulosusAntimicrobial Agents and Chemotherapy, 2006
- In Vitro Activities of Itraconazole, Methiazole, and Nitazoxanide versus Echinococcus multilocularis LarvaeAntimicrobial Agents and Chemotherapy, 2006